M. J. Ríos

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance

G. Moreno-Bueno, J. Palacios, P. Sánchez‐Rovira, 2007, Breast Cancer Research and Treatment.

Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity.

J. Ho, E. Wick, S. He, 1992, The Journal of infectious diseases.